Stocks and Investing
Stocks and Investing
Fri, November 15, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, November 14, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Madhu Kumar Initiated (VIR) at Hold and Held Target at $17 on, Nov 14th, 2019
Madhu Kumar of Baird, Initiated "Vir Biotechnology, Inc." (VIR) at Hold and Held Target at $17 on, Nov 14th, 2019.
Madhu has made no other calls on VIR in the last 4 months.
There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 0 agree with Madhu's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Madhu
- Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $25 on, Tuesday, November 5th, 2019
- Gena Wang of "Barclays" Initiated at Buy and Held Target at $25 on, Tuesday, November 5th, 2019
- Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $37 on, Tuesday, November 5th, 2019
Contributing Sources